Abstract
In the last 20-30 years the approach to metastatic breast cancer by chemotherapy has been largely studied. Anthracyclines, taxanes and, more recently, capecitabine and gemcitabine represent the breakthrough of treatment. In the next future the combination of chemotherapy and target therapy will be considered more frequently.
Original language | English |
---|---|
Journal | Annals of Oncology |
Volume | 17 |
Issue number | SUPPL. 5 |
DOIs | |
Publication status | Published - May 2006 |
Keywords
- Chemotherapy
- Metastatic breast cancer
- Trastuzumab
ASJC Scopus subject areas
- Cancer Research
- Oncology